Goldman Sachs analyst Corinne Johnson started Metsera (MTSR) with an Early-Stage Biotech rating.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Circle initiated, Charter upgraded: Wall Street’s top analyst calls
- Metsera initiated with an Overweight at Wells Fargo
- Metsera price target raised to $62 from $56 at Guggenheim
- Metsera obesity monotherapy data ‘looks competitive,’ says BofA
- Warner Bros. Discovery to split up, Qualcomm buying Alphawave Semi: Morning Buzz